LCTX icon

Lineage Cell Therapeutics

106 hedge funds and large institutions have $76.2M invested in Lineage Cell Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 13 closing their positions.

Holders
106
Holders Change
+1
Holders Change %
+0.95%
% of All Funds
1.71%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
24
Reduced
23
Closed
13
Calls
$83K
Puts
$4K
Net Calls
+$79K
Net Calls Change
-$92K
Name Market Value Shares Shares
Change
Shares
Change %
NFSG
101
Newbridge Financial Services Group
Florida
$6 5
1832 Asset Management
102
1832 Asset Management
Ontario, Canada
$5 5
XT
103
XTX Topco
Cayman Islands
-72,807 Closed
GCP
104
GSA Capital Partners
United Kingdom
-48,628 Closed
Ohio Public Employees Retirement System (OPERS)
105
Ohio Public Employees Retirement System (OPERS)
Ohio
-45,623 Closed
LP
106
LMR Partners
United Kingdom
-44,733 Closed
AIM
107
Athena Investment Management
California
-35,556 Closed
Principal Financial Group
108
Principal Financial Group
Iowa
-14,937 Closed
HTC
109
Haverford Trust Company
Pennsylvania
-13,612 Closed
PCM
110
Prelude Capital Management
New York
-11,465 Closed
BNP Paribas Financial Markets
111
BNP Paribas Financial Markets
France
-4,209 Closed
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
$0 333 -2,721 -89%
TCOV
113
Trust Company of Vermont
Vermont
-2,079 Closed
Fifth Third Bancorp
114
Fifth Third Bancorp
Ohio
-1,420 Closed
TAM
115
Tucker Asset Management
Colorado
-150 Closed
IAMOG
116
Investors Asset Management of Georgia
Georgia
-2 Closed
Simplex Trading
117
Simplex Trading
Illinois
Rockefeller Capital Management
118
Rockefeller Capital Management
New York
$0 280
CFGS
119
Concourse Financial Group Securities
Alabama
HFS
120
Hantz Financial Services
Michigan
$0 29
Group One Trading
121
Group One Trading
Illinois
NA
122
NewEdge Advisors
Louisiana
$0 12 +12 New